Singular Health Group's EBIT per Share for the
six
months ended in Dec. 2025 was A$-0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.02.
During the past 3 years, the average EBIT per Share Growth Rate was 22.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Singular Health Group's EBIT per Share or its related term are showing as below:
ASX:SHG'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 17.8 Med: 20.35 Max: 22.9
Current: 22.9
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Singular Health Group was 22.90% per year. The lowest was 17.80% per year. And the median was 20.35% per year.
ASX:SHG's 3-Year EBIT Growth Rate is ranked better than 65.97% of 529
companies
in the Healthcare Providers & Services industry
Industry Median: 11.8
vs ASX:SHG: 22.90
Singular Health Group (ASX:SHG) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Singular Health Group EBIT per Share Related Terms
Singular Health Group EBIT per Share Historical Data
* Premium members only.
The historical data trend for Singular Health Group's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singular Health Group (ASX:SHG) has a EBIT per Share of A$-0.02 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Singular Health Group and its competitors. According to the industry distribution chart, Singular Health Group ranks #180 out of 529 companies in the Healthcare Providers & Services industry, placing it in the top 34%.
Is Singular Health Group's EBIT per Share too high?
Singular Health Group's current EBIT per Share is A$-0.02. Based on the distribution chart, Singular Health Group ranks #180 out of 529 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Singular Health Group has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Singular Health Group's EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Singular Health Group ranks #180 out of 529 companies for EBIT per Share. This puts Singular Health Group in the upper half of its industry. The industry median EBIT per Share is 11.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Singular Health Group and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singular Health Group's current EBIT per Share is A$-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singular Health Group stock overvalued right now?
Based on GuruFocus' analysis, Singular Health Group (ASX:SHG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.11, compared to a current price of A$0.21 — trading 90.9% above its estimated fair value. The current EBIT per Share is A$-0.02. Singular Health Group's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Singular Health Group (ASX:SHG), the current EBIT per Share is A$-0.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Singular Health Group (ASX:SHG) Overvalued in 2026?
Based on GuruFocus' analysis, Singular Health Group stock appears to be overvalued.
The current stock price of A$0.21 is trading 90.9% above its estimated GF Value™ of A$0.11.
GuruFocus considers Singular Health Group to be Significantly Overvalued.
Key valuation signals for ASX:SHG:
EBIT per Share: A$-0.02
GF Value™: A$0.11 vs. price of A$0.21 (90.9% above fair value)
No single metric tells the full story. See the ASX:SHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
30GF Score
Get the complete analysis for ASX:SHG
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SHG has been successfully added to your 
